1. Home
  2. ORGO vs AAM Comparison

ORGO vs AAM Comparison

Compare ORGO & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORGO
  • AAM
  • Stock Information
  • Founded
  • ORGO 1985
  • AAM 2024
  • Country
  • ORGO United States
  • AAM United States
  • Employees
  • ORGO N/A
  • AAM N/A
  • Industry
  • ORGO Biotechnology: Pharmaceutical Preparations
  • AAM
  • Sector
  • ORGO Health Care
  • AAM
  • Exchange
  • ORGO Nasdaq
  • AAM Nasdaq
  • Market Cap
  • ORGO 465.6M
  • AAM 458.2M
  • IPO Year
  • ORGO N/A
  • AAM 2024
  • Fundamental
  • Price
  • ORGO $4.32
  • AAM $10.42
  • Analyst Decision
  • ORGO Hold
  • AAM
  • Analyst Count
  • ORGO 1
  • AAM 0
  • Target Price
  • ORGO $6.00
  • AAM N/A
  • AVG Volume (30 Days)
  • ORGO 918.2K
  • AAM 29.8K
  • Earning Date
  • ORGO 08-07-2025
  • AAM 01-01-0001
  • Dividend Yield
  • ORGO N/A
  • AAM N/A
  • EPS Growth
  • ORGO N/A
  • AAM N/A
  • EPS
  • ORGO N/A
  • AAM 0.30
  • Revenue
  • ORGO $458,760,000.00
  • AAM N/A
  • Revenue This Year
  • ORGO $1.10
  • AAM N/A
  • Revenue Next Year
  • ORGO $9.93
  • AAM N/A
  • P/E Ratio
  • ORGO N/A
  • AAM $34.81
  • Revenue Growth
  • ORGO 5.35
  • AAM N/A
  • 52 Week Low
  • ORGO $2.28
  • AAM $9.96
  • 52 Week High
  • ORGO $6.71
  • AAM $10.79
  • Technical
  • Relative Strength Index (RSI)
  • ORGO 68.34
  • AAM N/A
  • Support Level
  • ORGO $3.59
  • AAM N/A
  • Resistance Level
  • ORGO $4.70
  • AAM N/A
  • Average True Range (ATR)
  • ORGO 0.23
  • AAM 0.00
  • MACD
  • ORGO 0.12
  • AAM 0.00
  • Stochastic Oscillator
  • ORGO 81.15
  • AAM 0.00

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

About AAM AA Mission Acquisition Corp. Class A Ordinary Shares

AA Mission Acquisition Corp is a blank check company.

Share on Social Networks: